Most of sporadic AD cases are ApoE ε4 non-carriers (60%) observed in this and other studies, therefore, our findings shed light on the importance of identifying genetic markers in ApoE ε4 non-carriers. The gene discussed is APOE; the disease is Alzheimer disease.